Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Early-onset familial lewy body dementia with extensive tauopathy: a clinical, genetic, and neuropathological study.

Clarimón J, Molina-Porcel L, Gómez-Isla T, Blesa R, Guardia-Laguarta C, González-Neira A, Estorch M, Ma Grau J, Barraquer L, Roig C, Ferrer I, Lleó A.

J Neuropathol Exp Neurol. 2009 Jan;68(1):73-82. doi: 10.1097/NEN.0b013e3181927577.

PMID:
19104444
2.

The genetics of dementia with Lewy bodies: what are we missing?

Meeus B, Theuns J, Van Broeckhoven C.

Arch Neurol. 2012 Sep;69(9):1113-8. doi: 10.1001/archneurol.2011.3678. Review.

PMID:
22635379
3.

[Alzheimer's disease: lesions and their progression].

Duyckaerts C, Colle MA, Delatour B, Hauw JJ.

Rev Neurol (Paris). 1999;155 Suppl 4:S17-27. Review. French.

PMID:
10637934
4.

Emerging pathways in genetic Parkinson's disease: tangles, Lewy bodies and LRRK2.

Devine MJ, Lewis PA.

FEBS J. 2008 Dec;275(23):5748-57. doi: 10.1111/j.1742-4658.2008.06707.x. Review.

5.

Neuropathological spectrum of synucleinopathies.

Jellinger KA.

Mov Disord. 2003 Sep;18 Suppl 6:S2-12. Review.

PMID:
14502650
6.

Invited review: Neuropathology of tauopathies: principles and practice.

Kovacs GG.

Neuropathol Appl Neurobiol. 2015 Feb;41(1):3-23. doi: 10.1111/nan.12208. Review.

PMID:
25495175
7.

Genetic Disorders with Tau Pathology: A Review of the Literature and Report of Two Patients with Tauopathy and Positive Family Histories.

Tacik P, Sanchez-Contreras M, Rademakers R, Dickson DW, Wszolek ZK.

Neurodegener Dis. 2016;16(1-2):12-21. doi: 10.1159/000440840. Epub 2015 Nov 10. Review.

8.

The relationship between amyloid and tau.

Hardy J.

J Mol Neurosci. 2003 Apr;20(2):203-6. Review.

PMID:
12794314
9.

Familial Lewy body diseases.

Gwinn-Hardy K, Singleton AA.

J Geriatr Psychiatry Neurol. 2002 Winter;15(4):217-23. Review.

PMID:
12489918
10.

Recent advances in the genetics of dementia with lewy bodies.

Bonifati V.

Curr Neurol Neurosci Rep. 2008 May;8(3):187-9. Review.

PMID:
18541113
11.

LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?

Taylor JP, Mata IF, Farrer MJ.

Trends Mol Med. 2006 Feb;12(2):76-82. Epub 2006 Jan 10. Review.

PMID:
16406842
12.

MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies.

Labbé C, Heckman MG, Lorenzo-Betancor O, Soto-Ortolaza AI, Walton RL, Murray ME, Allen M, Uitti RJ, Wszolek ZK, Smith GE, Kantarci K, Knopman DS, Lowe VJ, Jack CR Jr., Ertekin-Taner N, Hassan A, Savica R, Petersen RC, Parisi JE, Maraganore DM, Graff-Radford NR, Ferman TJ, Boeve BF, Dickson DW, Ross OA.

Alzheimers Dement. 2016 Dec;12(12):1297-1304. doi: 10.1016/j.jalz.2016.05.002. Epub 2016 Jun 7. Review.

13.

Neurodegenerative dementia and parkinsonism.

Gabelle A, Portet F, Berr C, Touchon J.

J Nutr Health Aging. 2010 Jan;14(1):37-44. Review.

PMID:
20082052
14.

Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics.

Kovacs GG, Botond G, Budka H.

Acta Neuropathol. 2010 Apr;119(4):389-408. doi: 10.1007/s00401-010-0658-1. Epub 2010 Mar 3. Review.

PMID:
20198481
15.

Comorbidities.

Alafuzoff I, Kovacs GG.

Handb Clin Neurol. 2017;145:573-577. doi: 10.1016/B978-0-12-802395-2.00036-5. Review.

PMID:
28987195

Supplemental Content

Support Center